Lv51
1240 积分 2023-09-04 加入
A novel triple-knockout allogeneic BCMA CAR T-cell therapy (CT0590) for multiple myeloma: preclinical and phase 1 study
2小时前
待确认
CAR T-Cell Therapy for Glioblastoma
24天前
已完结
A novel triple-knockout allogeneic BCMA CAR T cell therapy (CT0590) in multiple myeloma: preclinical and phase I study
1个月前
已关闭
A novel triple-knockout allogeneic BCMA CAR T cell therapy (CT0590) in multiple myeloma: preclinical and phase I study
3个月前
已完结
Use of Early Intrathecal Therapy to Manage High-Grade Immune Effector Cell-Associated Neurotoxicity Syndrome
4个月前
已完结
A Phase II Study of Prophylactic Anakinra to Prevent CRS and Neurotoxicity in Patients Receiving CD19 CAR T Cell Therapy for Relapsed or Refractory Lymphoma
4个月前
已完结
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn
8个月前
已完结
GPRC5D-targeted CAR T-cell therapy (CT071) in patients with relapsed or refractory multiple myeloma: a first-in-human, single-centre, single-arm, phase 1 trial
10个月前
已关闭
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers
11个月前
已完结
Engineered T cell therapy for hepatocellular carcinoma: the dawn of precision immunotherapy?
11个月前
已完结
皖公网安备34019202002308
